PBM

financing money snag

Biotech

'By hook or crook': BIO CEO urges biotechs to persevere

Rachel King said few things would bring her out of retirement. Leading BIO just happened to be one of those things.

Gabrielle Masson Oct 25, 2023 10:10am

DNA

SalioGen raises $20M to validate non-viral gene therapy platform

Mar 1, 2021 8:00am

Taysha Gene Therapies CEO RA Sessions

Taysha debuts with $30M, 15 gene therapy programs

Apr 29, 2020 8:00am